Durvulumab-induced rheumatoid arthritis: A case report

Authors

DOI:

https://doi.org/10.46570/utjms.vol11-2023-953

Keywords:

Oncology, Checkpoint inhibitors, immunotherapy, Durvulumab, Rheumatoid arthritis
Journal Cover Art for Volume 11, Issue 3

Downloads

Published

2023-12-15

How to Cite

1.
Masharib Bashar, Aqsa Farooqui, Divya Vijendra. Durvulumab-induced rheumatoid arthritis: A case report . Translation [Internet]. 2023 Dec. 15 [cited 2025 Aug. 13];11(3). Available from: https://openjournals.utoledo.edu/index.php/translation/article/view/953

Issue

Vol. 11 No. 3 (2023): The 2023 Dr. Lance D. Dworkin Department of Medicine Research Symposium

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

License

Copyright (c) 2023 Masharib Bashar, Aqsa Farooqui , Divya Vijendra

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).